Faster, more efficient oncology clinical trials


Exactis has strong research relationships with a broad range of pharmaceutical and biotech companies developing new precision cancer therapies, allowing it to complete the connection among potential study sponsors, cancer treatment centres and Canadian patients.


Our Services

The innovative Exactis research network (consortium) meets a growing need of biopharmaceutical drug developers to study new precision treatments in rare populations of patients with very specific molecular profiles in their cancer.  Offering study sponsors faster and simpler patient enrolment for rarer cancer populations encourages clinical studies in Canada.

Learn more about PMT

Learn more about our Clinical Development Unit
Learn more about our Molecular Pathology Services

5450 Chemin de la Côte-des-Neiges

Suite 522

Montréal, Qc

H3T 1Y6


  • White LinkedIn Icon
Send Us a Message

© 2020 by Exactis Innovation